•
Anhui Tongling Bionic Technology Co., Ltd, a Chinese developer of cardiopulmonary circulatory assist equipment, has reportedly raised hundreds of millions of renminbi in a Series B financing round led by Weigao Holding’s fund. The proceeds will be used for product research and development and facilities construction. Company BackgroundFounded in 2016…